DSpace
 

University of Jos Institutional Repository >
Medical Sciences >
Medical Laboratory Sciences >

Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1688

Title: Sero-Epidemiological Survey of Human Cytomegalo Virus Infection among Expectant Mothers in Bida, Nigeria
Authors: Okwori, A.
Olabode, A.
Emumwen, E.
Echeonwu, G.
Lugos, M.
Okpe, E.
Okopi, J.
Adetunji, J.
Issue Date: 2008
Publisher: The Internet Journal of Infectious Diseases
Citation: A Okwori, A Olabode, E Emumwen, G Echeonwu, M Lugos, E Okpe, J Okopi, J Adetunji. Sero-Epidemiological Survey Of Human Cytomegalo Virus Infection Among Expectant Mothers In Bida, Nigeria. The Internet Journal of Infectious Diseases. 2008 Volume 7 Number 1.
Series/Report no.: Vol. 7;No. 1; Pp 1-5
Abstract: Human cytomegalovirus (HCMV) is a major public health problem throughout the world. Serological surveys have shown HCMV infection in virtually every population that have been tested. HCMV is a known cause of congenital defects in babies of infected mothers. This work was aimed at determining the seroprevalence of HCMV among pregnant women. The prevalence of HCMV infections among two hundred and fifty three (253) pregnant women attending ante-natal clinic at the Federal Medical Centre, Bida between the months of November, 2004 and January, 2005 was studied. Serological screening for HCMV antibodies was done using Immunocomb® 11 IgG and ImmunoLISA TM CMV IgG. Two hundred and thirteen (213) (84.2%) were positive. Prevalence of HCMV was higher among multigravid women (86.1%) than primigravid women (77.1%). More of the pregnant women who are non-health workers (84.6%) had CMV antibodies in their sera than health workers (25.0%). There was a significant association in HCMV seroprevalence (p<.05) between health workers and non – health workers. The prevalence of HCMV was highest (87.5%) among the Teenage pregnant (TP) women. There were higher seroprevalence of HCMV in second trimester (ST) (86.2%) than the first trimester (FT) (81.4%) and third trimester (TT) (75.9%). It is concluded that there is high seroprevalence of HCMV among pregnant women investigated. It is hereby advocated that relevant vaccines should be made available to protect women of child bearing age and pregnant women.
URI: http://hdl.handle.net/123456789/1688
Appears in Collections:Medical Laboratory Sciences

Files in This Item:

File Description SizeFormat
ispub-11087.pdf443.8 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2010  Duraspace - Feedback